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The induction of a mutator phenotype has been hypothesized to cause the accumulation of multiple
mutations in the development of cancer. Recent evidence suggests that the mutator phenotype
is associated with DNA repair deficiencies. We have been using a challenge assay to study
exposed populations to test our hypothesis that exposure to environmental toxicants can induce
DNA repair deficiency in somatic cells. In this assay, lymphocytes were irradiated in vitro to
challenge cells to repair the radiation-induced DNA strand breaks. An increase of chromosome
aberrations in the challenged cells from toxicant-exposed populations compared to nonexposed
populations is used to indicate abnormal DNA repair response. From studies of cigarette smokers,
butadiene-exposed workers, and uranium-exposed residents, the assay showed that these
exposed populations had mutagen-induced abnormal DNA repair response. The phenomenon
was also demonstrated using experimental animals. Mice were exposed in vivo to two different
doses of N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) and their lymphocytes were challenged
with one dose of a radiomimetic chemical, bleomycin, in vitro. These challenged lymphocytes
showed an MNNG dose-dependent increase of abnormal DNA repair response. In a population
that was potentially exposed to teratogens-mothers having children with neural tube defects-
lymphocytes from these mothers did not have the abnormal response in our assay. In studies
with patients, we reported that lymphocytes from Down's syndrome patients have the abnormal
DNA repair response. Lymphocytes from skin cancer-prone patients (epidermodysplasia verruci-
formis) have normal response to -ray challenge but abnormal response to UV-light challenge.
These patient studies also indicate that the challenge assay is useful in documenting the
radiosensitivity of Down's syndrome and the UV sensitivity in EV patients. In most cases, the
challenge assay is more sensitive in detecting biological effects than the standard chromosome
aberration assay. Our series of studies indicates that the challenge assay can be used to docu-
ment biological effects from exposure to mutagens and that the effect is an abnormal DNA repair
response. This abnormality can increase the risk for development of cancer. The repair deficiency
is currently being validated using a plasmid transfection (host-reactivaton) assay. The need to
integrate chromosome aberration and the challenge assays with other relevant assays for better
documentation of biological effects and for more precise prediction of health risk will be
presented. Our experience in using genetic polymorphism and host-reactivation assays will be
discussed. Environ Health Perspect 104(Suppl 3):579-584 (1996)
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Introduction
There is increased interest in using biologi-
cal markers to monitor populations for
identification ofexcessive exposure to envi-
ronmental toxicants. The ultimate goal is
to use these biomarker data to indicate
early disease and to predict increased risk
for development oflong-term health con-
sequences. The choice of biomarkers for
population studies will therefore determine
the usefulness of the results in public
health. In addition, the sensitivity of the
assay should be taken into consideration.
Some of the assays have been very useful
and have had adequate sensitivity in docu-
menting biological effects ofexposed work-
ers in the past; however, with improved
work conditions through environmental
engineering, current workers are usually
exposed to smaller amounts of toxicants
than before. Furthermore, through auto-
mation ofindustrial processes, fewer work-
ers are employed in these industries. This
may cause problems with studies that
require substantial population sizes for
analyses. With recent attention focused on
hazardous waste sites, population studies
are not limited to investigating workers but
have been extended to the general public.
Residents living around hazardous areas are
assumed to be exposed to less toxicant than
allowed at the occupational levels, based on
air sampling data. In addition, the exposure
conditions for the public are different from
those for the workers. Therefore, studies
involving the general public require addi-
tional considerations regarding experimental
design and choice ofbiomarkers.
Chromosome aberration is one of the
most extensively used biomarkers for popu-
lation monitoring. It is often considered a
gold standard for documentation of bio-
logical effects in exposed populations.
Furthermore, unlike most other biomark-
ers, existence of chromosome aberrations
has been shown to be associated with
health effects. For example, chromosome
aberration is frequently used as an internal
biological dosimeter for exposure to ioniz-
ing radiations (1,2), and the dose-response
relationship ofchromosome aberration to
exposure is similar to that for leukemia
mortality (3). In a prospective cohort
study, populations with increased chromo-
some aberrations have higher leukemia
mortality than those with lower chromo-
some aberrations (4,5). Therefore, this
biomarker can be used to predict health
consequences. One drawback ofthis gold
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standard assay is that it may not have the
sensitivity to detect effects after exposure
to very low doses oftoxicants. For exposure
to ionizing radiations, the detection limit
is of the order of 10 cGy for recent expo-
sure (6), but the detection limits for other
biomarkers are mostly unknown. There-
fore, for population studies, it is prudent to
use the standard chromosome aberration
assay in conjunction with newer assays
such as the fluorescence in situ hybridiza-
tion assay for detecting balanced chromo-
some translocations (7-9) and challenge
assays to detect abnormal DNA repair
response leading to the development of
chromosome alterations.
Carcinogenesis is a multistage process
involving multiple and sequential genetic
alterations. It has been proposed that an
initial step for the development of cancer
involves the induction ofa mutator pheno-
type (10). Recent evidence suggests that
the phenomenon of mutator phenotype
leading to genetic instability may be caused
by DNA repair deficiency (11,12); this
repairdeficiency maybe caused byexposure
to environmental toxicants. For example,
tire-storage workers exposed to nitroso-
compounds and hospital personnel exposed
to antineoplastic drugs were deficient in
methylguanine alkyltransferase activities
(13,14). Abnormal repair synthesis was
documented in lymphocytes of cigarette
smokers and drug addicts when their cells
were challenged with UV light or chemicals
(15-17). We have used a challenge assay to
detect abnormal DNA repair response. In
this assay, lymphocytes from toxicant-
exposed and nonexposed individuals are
irradiated during the G1 phase in vitrowith
precise doses of ionizing radiation to
induce DNA strand breaks; these cells are
challenged to repair the radiation-induced
damage. The assumption is that lympho-
cytes from toxicant-exposed individuals
will have DNA repair deficiency due to
modification of DNA/proteins (e.g.,
adducts) or mutation ofDNA repair genes
and will make more mistakes in repairing
the DNA strand breaks than lymphocytes
from controls. Since the radiation-induced
DNA damage and repair occur during the
G, phase as determined by our experimen-
tal protocol, cells from toxicant-exposed
individuals will have more chromosome-
type abnormalities than those from con-
trols (18). The significance ofDNA repair
deficiency in the carcinogenic process
is that such abnormality causes multiple
and sequential genetic alterations in cells,
thus promoting the evolution of genetic
changes that are relevant to the development
ofcancer.
The following is a description of our
work using the challenge assay to detect
abnormal DNA repair response in exposed
populations. We will present the possibil-
ity of integrating several biomarkers in
population studies to predict health risk.
Methods
ChallengeAssay
The challenge assay was performed using
lymphocytes from human populations and
from mice. Blood cultures were set up
according to standard procedures using
RPMI medium (19,20). At 24 hr after
initiation ofcultures, cells were exposed to
specific doses ofradiation or to a radiomi-
metic chemical, bleomycin. Immediately
after irradiation or treatment with chemi-
cal, bromodeoxyuridine was added to
each culture (final concentration 10 pM)
to label cells for identification oftheir pro-
liferation patterns. These cultures were
wrapped with aluminum foil to prevent
exposure to light and were maintained in a
humidified 5% CO2 atmosphere and at
370C. At 50 hr after initiation ofhuman
lymphocyte cultures, colcemid was added
to each culture to arrest cells in mitosis. For
mouse lymphocyte cultures, colcemid was
added at 41 hr after initiation ofcultures.
One hr later, the cultures were harvested
and slides were prepared. The slides were
stained using the fluorescence-plus-Giemsa
technique and viewed under a microscope
to select cells having the first metaphase





Lymphocytes from six young Down's
syndrome patients and six age-matched con-
trols were investigated using the challenge
assay (21). The unchallenged (background)
frequencies of chromosome aberrations
were the same for both groups of partici-
pants. After challenging the cells with 150
cGy X rays at the Go and G1 phases ofthe
cell cycles, the Down's syndrome cells had
significantly more chromosome aberra-
tions, thus abnormal DNA repair response,
than the controls (p<0.02). The percent-
ages of aberrant cells from the G0-irradi-
ated cells were 34.3 ±4.5 and 26.7 ± 9.0 for
Down's syndrome and controls, respectively.
The frequencies for the GI-irradiated cells
were 36.2 ± 7.1 and 27.0 ± 8.8, respectively.
Furthermore, the locations ofthe break sites
were preferentially distributed at cancer
break points and oncogene locations (22).
Epidermodysplasia verruciformis (EV)
patients are known to have a very high
incidence ofsunlight-induced skin lesions.
Lymphocytes from three EV patients and
their matched controls were investigated
using our challenge assay (23). It was
found that these cells responded to y-ray
challenge like normal cells; however, when
these cells were challenged with UV light
(4 or 2+2 J/m2; the combined doses were
each separated by 1 hr), the EV lympho-
cytes had significantly more chromosome
aberrations than the controls (p<0.05).
ChallgeAssayUsing
Heavy cigarette smokers (n = 12) who had
been consuming over 1 pack ofcigarettes
per day for over 10 years and matched
nonsmokers (n = 8) were recruited for
investigating the effect ofcigarette smoking
on DNA repair response (19). The back-
ground chromosome aberration frequencies
were similar to each other for both groups
ofparticipants; however, when their lym-
phocytes were irradiated with 100 + 100
cGy y rays (the two doses were separated
by 1 hr), those from cigarette smokers
had 1.35 times more dicentric frequencies
than the nonsmokers (Figure 1) and the
difference was significant atp<0.05.
Ten butadiene-exposed workers and 10
matched nonexposed co-workers were
recruited for our study (24). The mean
exposure dose for the target population was
3.5 ppm and for the control it was 0.03
ppm. The background chromosome aber-
ration frequency for the exposed popula-
tion was higher than that for the control,
but the difference was not significant. After
the challenge with 100 cGy y rays, the
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Smokers Uranium Butadiena Brownsville
Figure 1. DNA repair response of exposed populations
compared with matched controls based on challenge
assay.
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exposed group had a significantly higher
percentage ofaberrant cells and dicentric
frequency per 100 cells than the controls
(p<0.05, Figure 1). In addition, the dicen-
tric frequency for each exposed worker
was significantly correlated with the con-
centration ofa butadiene metabolite [1,2-
dihydroxy-4(N-acetylcysteinyl-S)butane]
in urine of these workers (correlation of
coefficient of0.6 withp<0.01).
Residents living around uranium min-
ing/milling sites are potentially exposed to
mining waste. A study was conducted to
investigate whether living in such an envi-
ronment could have increased health risk.
Twenty-four residents in the target area
and 24 matched residents in a control area
were recruited for our study (25). None of
the participants worked in the uranium
industry and none of them were cigarette
smokers. The target residents were found
to have a slightly higher frequency ofback-
ground chromosome aberrations than the
controls, although the difference was not
significant. After their lymphocytes were
challenged with 100 cGy y rays, the target
residents had a significantly higher percent-
age of aberrant cells than the controls
(p<0.05, Figure 1). In addition, the dicen-
tric frequency ofthe target population was
higher than that ofthe controls (p<0.25).
From 1989 to 1991, a cluster ofchil-
dren with neural tube defects was detected
in Brownsville, Texas. A study using the
challenge assay was conducted on mothers
with affected children to determine whether
exposure to environmental mutagens could
be a cause of the health problems (26).
Nineteen of the targeted mothers were
recruited and matched with 14 mothers
who had normal children. Lymphocytes
from these women were challenged with
100 cGy y rays. Our study indicates that
there was no difference in the background
or the challenged chromosome aberration
frequencies between the target and control
mothers (p>0.5, Figure 1).
ChaliengeStudywith
ExperimentalAnimals
Experiments were conducted using mice to
mimic human conditions to investigate
whether in vivo exposure to mutagens
would cause abnormal DNA repair response
when their lymphocytes were challenged in
vitro with a DNA-damaging agent. Male
C57Bl/6 mice weighing 15 to 20 gm were
intraperitoneally injected two times with
25 or 50 mg/Kg N-methyl-N'-nitro-N-
nitroso guanidine (MNNG), a minimally
clastogenic mutagen. The two doses were
separated by 24 hr. At 8 hr after the second
injection, mice were sacrificed and lym-
phocytes were removed for establishment
ofcell cultures according to the procedure
ofAu et al. (20). At 24 hr after initiation
ofcell cultures, lymphocytes were exposed
to 3 jig/ml bleomycin, a radiomimetic
agent. Cells were harvested at 42 hr.
Lymphocytes from untreated mice, mice
treated with MNNG alone, and lympho-
cytes treated with bleomycin in vitro alone
were used as controls. Itwas found that the
frequency ofchromosome aberrations from
lymphocytes with the combined treatment
was significantly higher than those expected,
based on simple additive effects from each
of the agents MNNG and bleomycin
(p<0.01; Figure 2).
Discussion
Using the challenge assay, we have shown
that the radiosensitivity that has been docu-
mented in Down's syndrome patients may
be caused by their abnormal DNA repair
response to ionizing radiation. In another
study, lymphocytes from EV patients had
normal response to the same challenge by
yrays; however, theyhad abnormal response
after exposure to UV light. This abnormal-
ity is consistent with EVpatients' increased
incidence ofcutaneous cancer in sunlight-
exposed skin. The data suggest that the
challenge assay can be used to document
abnormal DNA repair response.
Using cigarette smokers, butadiene-
exposed workers, and uranium-exposed
residents, we have shown that the challenge
assay is capable ofdetecting excessive expo-
sure to toxicants as indicated by their expres-
sion of abnormal DNA repair response
(19,24,25). In particular, the abnormal
response among butadiene-exposed work-
ers was significantly correlated with a buta-
diene metabolite in the urine of these
workers, indicating a cause-effect relation-
ship (24). For butadiene-exposed workers
and uranium-exposed residents, the spon-
taneous chromosome aberration frequen-
cies ofthe exposed populations were higher
than those from their matched controls,
although the difference was not significant.
This indicates that their exposures to toxi-
cants may be too low to be detectable by
the standard chromosome aberration assay.
For the uranium-exposed residents, this
indicates that their exposure to ionizing
radiation was lower than the maximal per-
missible occupational doses or less than
10 cGy acute exposure to high-LET radia-
tion (6). The results also indicate that the











Figure 2. DNA repair response in mice exposed to N-
methyl-N'-nitro-N-nitroso-guanidine (MNNG) in vivo
and then bleomycin in vitro.
abnormal DNA repair response and that
the challenge assay is more sensitive than
the standard chromosome aberration assay
in detecting biological effects from exposure
to toxicants. Although the mechanisms for
the abnormal DNA repair response are not
known, the abnormality may be caused by
blockage ofrepair processes on DNA (e.g.,
adducts) or by mutation ofgenes that code
for DNA repair enzymes (18). Because the
DNA repair process involves multiple
enzymes, it represents an enormous target
for insult by toxicants. In addition, because
many ofthe same repair enzymes serve on
multiple repair pathways, we hypothesize
that DNA repair defects caused by differ-
ent toxicants can be detected using only
y-ray challenge. The abnormal DNA repair
response will cause cells from affected indi-
viduals to make more mistakes in the
repair of DNA damage, especially from
further exposure to mutagens. The abnor-
mality may cause these populations to have
increased health risk.
In our study with mothers who had
children with neural tube defects, no differ-
ence in chromosome aberrations or abnor-
mal DNA repair response was detected in
the affected mothers compared with the
unaffected controls (26). This suggests
that the affected mothers may not have
been exposed excessively to environmental
mutagens; however, their exposure to ter-
atogens leading to the birth of children
with malformations cannot be ruled out.
To characterize the abnormal DNA
repair response further, we have been work-
ing on a host-reactivation assay to docu-
ment DNA repair deficiency. This assay
uses a pCMVcat plasmid containing a
chloramphenicol acetyltransferase (CAT)
reporter gene (27). The plasmids are irra-
diated with UV light to inactivate the
reporter gene before transfection. After
transfection, successful repair of the
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UV-induced damage on the reporter gene
by the host cells will allow expression of
the gene. A unique feature ofthe CMVcat
assay is that it measures the entire DNA
repair process rather than one step ofthe Exposure
process. We have confirmed that the assay
is sensitive enough to distinguish the repair
deficiency ofheterozygous xeroderma pig-
mentosum patients from homozygotes and
from nonxeroderma pigmentosum cells
(28). In addition, the assay has been suc-
cessfully field tested with lymphocytes Figure3. Fl
from workers exposed to benzene (28).
Although we observed reduced repair in lung can
cells from benzene-exposed workers com- activatec
pared with matched controls, the differ- gen, 4-(r
ence was not significant (28). The inability dyl)-1-b
to detect the difference between the two sister chr
groups may be because of the very low nonsmok
exposure concentrations (< 0.3 ppm) to Altho
benzene for the exposed workers. Our complex,
observation is consistent with the lack of seems tc
HPRTgene mutation in the same popula- (11,34,3'
tion (Ward, personal communication). an experi
Experiments using the assay on butadiene- the proc
exposed workers to further elucidate the mammar
sensitivity ofthis assay are ongoing. carcinog
For evaluation ofhealth risk in exposed lished ar
populations, variable individual/population genetic
response to toxicants must be taken into transforn
consideration. For example, it has been following
well documented that only approximately At the ea
10% of cigarette smokers develop lung normal n
cancer; therefore, there may be predisposed chromos
individuals in the population who make up lowed b)
a subpopulation with the highest risk. The stabilized
ability to identify the predisposed individu- stage, th(
als may be very helpful in reducing health they did
effects in exposed populations. One ofthe into hos
mechanisms for predisposition is polymor- expressioi
phism in genes for metabolism of xeno- which wa
biotics. With the advancement in molecular the c-myi
biology, individuals can be genotyped for cells tha
polymorphism of several genes (29,30). malignan
We have been conducting genotyping in the tra
studies to investigate the relationship by the tr;
between specific genetic polymorphisms the Rb-d
and abnormal response to specific environ- transfecte
mental toxicants as an indication ofpredis- sion in h
position and increased health risk. This together
approach is used similarly by several inves- that dete
tigators (31,32). We found that genetic occur alc
polymorphism for the CYP2EI gene is allow us













lowdiagram of biomarkers for health effects.
icer patients and that their cells
d a cigarette smoke procarcino-
methylnitroso amino)-1-(3-pyri-
utanone (NNK), to cause more
romatid exchanges than cells from
cers (33).
4ugh the carcinogenic process is
I a simple and common pathway
D be involved for most cancers
5). In our laboratory we have used
imental animal model to elucidate
cess (36-38). In these studies,
ry cells from mice irradiated with a
,enic dose ofX rays were estab-
nd investigated sequentially for
changes that lead to malignant
nation ofthe irradiated cells. The
sequential changes were observed.
arly stages the cultured cells were
rnorphologically but had extensive
some instability, which was fol-
y the evolution of cells having a
i but abnormal karyotype. At this
e cells were not transformed and
not form tumors upon injection
it mice. Later, the cells lost the
In ofthe retinoblastoma (Rb) gene,
as followed by the amplification of
cprotooncogene. At this stage, the
Lt appeared transformed became
t. The involvement ofthe Rbgene
Lnsformation process was confirmed
*ansfection ofnormal Rb gene into
leficient and malignant cells. The
ed cells lost their malignant expres-
lost mice. Our studies (36-38),
with those from others, indicate
ection of biological effects which
rng the common pathway should
to identify the toxicant-induced
fects with confidence.
In our laboratory we have been inte-
grating the relevant biomarkers into our
research program for evaluation ofhealth
risk in exposed populations (Figure 3).
The initial step ofthis process is the docu-
mentation ofexposure for the target popu-
lations through environmental monitoring
(39). This is followed by documentation
of internal exposure (e.g., butadiene
metabolites in urine ofbutadiene-exposed
workers) (24,40). Under certain condi-
tions, individuals with genetic polymor-
phism for metabolism and detoxification
ofxenobiotics may be at the highest risk
for exposure to specific toxicants in an
exposed population (33). Our assumption
is that excessive exposure to toxicants will
cause DNA damage, abnormality in DNA
repair, and genetic instability. We intend
to document these changes by using a
variety ofassays: chromosome aberration,
challenge assays, and host reactivation
assays. Finally, we intend to detect changes
in specific genes (e.g., oncogenes and
tumor suppressor genes) as an indication
ofhealth consequences.
In summary, the challenge assay is
demonstrated to be useful in monitoring
exposed populations for toxicant-induced
abnormal DNA repair response. Based on
our experimental data, we estimate that if
we use a sample size of 12 per group, we
should be able to detect a difference of
10% in dicentric frequency with statistical
confidence. The assay should, however,
be used with other relevent assays such
as genetic polymorphism, host reactivation,
gene mutation, and molecular genetic
assays for better documentation ofbiologi-
cal effects from exposure to toxicants and
for more precise prediction ofhealth risk.
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